Needham & Company Upgrades Imperva (IMPV) to Buy Amid Potential Sale; $64 PT

August 5, 2016 7:27 AM EDT
Get Alerts IMPV Hot Sheet
Price: $40.90 +1.36%

Rating Summary:
    19 Buy, 10 Hold, 1 Sell

Rating Trend: Up Up

Today's Overall Ratings:
    Up: 22 | Down: 32 | New: 34
Trade IMPV Now!
Join SI Premium – FREE

News and research before you hear about it on CNBC and others. Claim your 2-week free trial to StreetInsider Premium here.

Needham & Company upgraded Imperva (NYSE: IMPV) from Hold to Buy with a price target of $64.00, as Qatalyst hired for a potential sale.

Analyst Scott Zeller commented, "Our IMPV downgrade post MarQ was based on our lack of confidence that IMPV could achieve its forecast for the year. IMPV missed in JuneQ and shares have since recovered from a low near $35, up to the current $45 range. Last night’s call with full details of the JuneQ miss lowered the bar materially, with CY16 guidance going down -18% from $305.5m to $249.6m at the midpoint. We believe the bar has now been lowered sufficiently for IMPV for CY16. The official news on the call of Qatalyst being hired confirms recent speculation, and we believe activist Elliott will likely be rewarded with a sale of IMPV. Valuation? Currently, shares are at 4x EV/CY17 on a very low bar of $318m in CY17. We estimate IMPV would be worth 6x EV/CY17 revenues or greater in a potential sale. Upgrade to BUY, new target $64, based on 6x EV/CY17 revenue."

For an analyst ratings summary and ratings history on Imperva click here. For more ratings news on Imperva click here.

Shares of Imperva closed at $45.01 yesterday.

Serious News for Serious Traders! Try Premium Free!

You May Also Be Interested In

Related Categories

Analyst Comments, Hot Upgrades, Rumors, Upgrades

Related Entities

Needham & Company

Add Your Comment